trial · primary record
Risankizumab
Crohn's Disease
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 2000 |
| Primary completion | 2031-10 |
| Primary endpoint | Crohn's Disease Specific: Percentage of Participants Achieving Endoscopic Remission |
| Registry ID | NCT07697456 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:31:40.915Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07697456
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.